menu Home

Program

  • DAY 1 / Sep. 11 (Fri)
  • DAY 2 / Sep. 12 (Sat)

DAY 1 / Sep. 11 (Fri)

Overall Moderator: Jong Wook KIM (Korea)

09:00-09:50 Registration
09:00-09:50 E-Poster Session (Non-moderated poster presentation)
09:50-10:00 Opening / Welcome Remarks

Jae Young JOUNG (President, the Korean Prostate Society)
Sung Kyu HONG (President, Asia Pacific Society of Uro-oncology)
Seong IL SEO (President, the Korean Urological Association)
Session I. Prostate Cancer I : Surgical Treatment for Localized Prostate Cancer
Time 10:00-11:15
Chair(s) Tag Keun YOO (Korea)
Jae Young PARK (Korea)
Lukman HAKIM (Indonesia)
Speaker(s) 10:00-10:15 RARP with da Vinci multiport: Key Steps for Nerve Sparing and Urethral Preservation — Surgical Video Tips
Hisamitsu IDE (Japan)
10:15-10:30 Laparoscopic Radical Prostatectomy in 2026: Still Relevant? Tips for Precision Dissection
Jong Wook PARK (Korea)
10:30-10:45 NeuroSAFE and Beyond: Current and Emerging Technologies for Intraoperative Surgical Margin Assessment in Radical Prostatectomy
Su Jung Oh-Hohenhorst (Germany)
10:45-10:55 From Cognitive MRI to Real-Time Augmented Reality Overlay in RARP
Se Young CHOI (Korea)
10:55-11:15 Case-based Panel Discussion

Moderator: Seong Hyeon YU (Korea)
Panel: Gyeong Eun MIN (Korea)   |   Yun Beom KIM (Korea)   |   Jong Wook PARK (Korea)
Se Young CHOI (Korea)
11:15-11:40 Coffee Break
Session II. Prostate Cancer II : Locally Advanced Prostate Cancer
Time 11:40-12:45
Chair(s) Seong Il SEO (Korea)
U-Syn HA (Korea)
Jacob See-Tong PANG (Taiwan)
Speaker(s) 11:40-12:00 AI in the Management of Prostate Cancer: Initial Experience from Shanghai
Rui Chen (China)
12:00-12:07 Adjuvant vs. Early Salvage Radiotherapy After RP — When to Irradiate and How?
Yun Sok HA (Korea)
12:07-12:14 Role of Extended PLND in High-risk Prostate Cancer in the PSMA PET Era
Yong Hyun PARK (Korea)
12:14-12:21 Overtreatment vs. Undertreatment in cN1M0 Disease: Optimal Treatment Strategy
Bum Sik TAE (Korea)
12:21-12:45 Case-based Panel Discussion

Moderator: Hyun Ho HAN (Korea)
Panel: Sung Dae KIM (Korea)   |   Won Tae KIM (Korea)   |   Vincent Fradet (Canada)
Shian-Shiang WANG (Taiwan)   |   Yun Sok HA (Korea)   |   Yong Hyun PARK (Korea)
Bum Sik TAE (Korea)
Lunch & Luncheon Symposium
Time 12:45-13:45
Chair(s) Jae IL CHUNG (Korea)
Speaker(s)   From Clinical Evidence to Clinical Practice: Implementing PSMA Radioligand Therapy in the Real World
William K. Oh (USA)
Session III. Prostate Cancer III : Focal & Ablative Therapy for Localized Prostate Cancer
Time 13:45-14:50
Chair(s) Moon Ki JO (Korea)
Hwang Gyun JEON (Korea)
Speaker(s) 13:45-13:52 Follow-up After Focal Therapy: When to Re-biopsy, When to Re-treat, When to Switch
Hee Jo YANG (Korea)
13:52-13:59 Who is NOT a Candidate for Focal Therapy? 2026 Guideline Consensus
Sang Wook Lee (Korea)
13:59-14:06 Salvage Treatment after Focal Therapy Failure
Hyung Joon KIM (Korea)
14:06-14:26 Principles of Focal Therapy in Localized Prostate Cancer: Patient Selection, Energy Sources & Follow-up Protocol
Po-Hung, LIN (Taiwan)
14:26-14:50 Case-based Panel Discussion

Moderator: Joong Won CHOI (Korea)
Panel: Myung Soo KIM (Korea)   |   Hee Jo YANG (Korea)   |   Sang Wook LEE (Korea)
Po-Hung, LIN (Taiwan)   |   Won Ik SEO (Korea)   |   Hyung Joon KIM (Korea)
14:50-15:10 Coffee Break
Session IV. Prostate Cancer IV : Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Time 15:10-16:40
Chair(s) Sung Kyu HONG (Korea)
Jun Sung KOH (Korea)
William K. Oh (USA)
Speaker(s) 15:10-15:25 PSMA in Prostate Cancer: From Biology to Clinical Application
Naoya Nagaya (Japan)
15:25-15:40 Doublet vs. Triplet Intensification in mHSPC: Who Truly Needs More Than Two Drugs? Patient Selection Algorithm 2026
Joseph W KIM (USA)
15:40-15:55 Optimized Strategies in mHSPC Therapy: Balancing between Clinical Efficacy and Treatment Burden for Improving Long-term Outcomes
Kuan Chou Chen (Taiwan)
15:55-16:10 Evidence-based Role of Radiotherapy in mHSPC
Jason Chia-Hsien Cheng (Taiwan)
16:10-16:40 Case-based Panel Discussion

Moderator: Sang Hun SONG (Korea)
Panel: Soo Dong KIM (Korea)   |   Naoya Nagaya (Japan)   |   Joseph W KIM (USA)
Kuan Chou Chen (Taiwan)   |   Jason Chia-Hsien Cheng (Taiwan)   |   Fumihiko URABE (Japan)
16:40-16:50 Day 1 Closing / Announcements
17:30-19:30 Banquet

DAY 2 / Sep. 12 (Sat)

Overall Moderator: Jong Wook KIM (Korea)

Session V. Prostate Cancer V : Emerging Biomarkers and Evolving Biopsy Strategies
Time 09:10-10:25
Chair(s) Choung Soo KIM (Korea)
Jun Hyuk HONG (Korea)
Edmund CHIONG (Singapore)
Speaker(s) 09:10-09:30 Liquid Biopsy in Prostate Cancer: Current Clinical Applications and Future Perspectives
Fumihiko URABE (Japan)
09:30-09:50 Gut Microbiome and Prostate Cancer
Vincent Fradet (Canada)
09:50-09:57 PSMA PET/CT after Equivocal MRI: Can We Halve Unnecessary Biopsies? (PRIMARY2 RCT)
See Min CHOI (Korea)
09:57-10:04 Transperineal vs Transrectal Biopsy updates: TRANSLATE Trial
Teak Jun SHIN (Korea)
10:04-10:25 Case-based Panel Discussion

Moderator: Jong Soo LEE (Korea)
Panel: Phil Hyun SONG (Korea)   |   Kyo Chul KOO (Korea)   |   Duc Minh PHAM (Vietnam)
See Min CHOI (Korea)   |   Teak Jun SHIN (Korea)
10:25-10:50 Coffee Break
Session VI. Urothelial Cancer : NMIBC, MIBC & UTUC — Novel Therapies & Precision Medicine
Time 10:50-11:55
Chair(s) Byong Chang JEONG (Korea)
Seok Ho KANG (Korea)
Teng Aik ONG (Malaysia)
Speaker(s) 10:50-11:10 UTUC & Synchronous Bladder Cancer: Staging, Sequencing & Treatment Strategies - Taiwan Experience
Shian-Shiang WANG (Taiwan)
11:10-11:17 FGFR-targeted Therapy in NMIBC: Intravesical Erdafitinib (TAR-210) & Oral Dabogratinib (SURF302)
Tae Young PARK (Korea)
11:17-11:24 Neoadjuvant & Perioperative Therapy for MIBC: EV+Pembrolizumab (KEYNOTE-B15) & NIAGARA (Durvalumab+GemCis)
Se Yun KWON (Korea)
11:24-11:31 Bladder Preservation After NAC in MIBC: Cystectomy vs. Organ-sparing Approaches
Jong Kil NAM (Korea)
11:31-11:55 Case-based Panel Discussion

Moderator: Sung Goo YOON (Korea)
Panel: Jung Ki JO (Korea)   |   Hyun Young LEE (Korea)   |   Lukman HAKIM (Indonesia)
Po-Hung, LIN (Taiwan)   |   Tae Young PARK (Korea)   |   Se Yun KWON (Korea)   |   Jong Kil NAM (Korea)
11:55-12:10 KPS BLUE Award

Jae Young JOUNG (President, the Korean Prostate Society)
Lunch / Luncheon Symposium
Time 12:10-13:20
Chair(s) Kyung Seop LEE (Korea)
Speaker(s) 12:10- Navigating mHSPC: Clinical evidence supporting the efficacy of Apalutamide
Se Young CHOI (Korea)
Session VII. Prostate Cancer VI : Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Time 13:20-14:40
Chair(s) Taek Won KANG (Korea)
Jae Seung CHUNG (Korea)
Kuan Chou Chen (Taiwan)
Speaker(s) 13:20-13:40 Current status and challenges in mCRPC treatment
Hiroji UEMURA (Japan)
13:40-14:00 Can We Predict Treatment Response in Prostate Cancer? Patient-derived Organoids & Treatment Response Prediction
Su Jung Oh-Hohenhorst (Germany)
14:00-14:20 Emerging Therapies in mCRPC: T Cell Engagers, ADCs and Bifunctional Proteins
Joseph W KIM (USA)
14:20-14:40 Case-based Panel Discussion

Moderator: Dong Ho SHIN (Korea)
Panel: Sang Chul LEE (Korea)   |   Won Hoon SONG (Korea)   |   Edmund CHIONG (Singapore)
Hisamitsu IDE (Japan)   |   Hiroji UEMURA (Japan)   |   Su Jung Oh-Hohenhorst (Germany)
Joseph W KIM (USA)
Satellite symposium
Time 14:40-15:00
Chair(s) Seok Joong YUN (Korea)
Speaker(s) 14:40-15:00 The New Treatment Option for Male LUTS: Vesomni
Jae Heon KIM (Korea)
15:00-15:20 Coffee Break
Session VIII. Surgical Treatment of Benign Prostatic Hyperplasia (BPH) : Laser Surgery, Minimally Invasive Techniques & Postoperative Management
Time 15:20-16:30
Chair(s) Tae Hyo KIM (Korea)
Jong Wook PARK (Korea)
Speaker(s) 15:20-15:35 Beyond the Standard: Shaping the New Era of BPH Surgery with MIST (UroLIFT, Rezum, iTind)
Ji Hoon AHN (Korea)
15:35-15:50 HoLEP in 2026: Who Should Still Be Doing It and How to Optimize Results
Chung Lyul LEE (Korea)
15:50-16:05 Robot Simple Prostatectomy - Approach, Urethral Reconstruction & Outcomes in Large Glands
Tae Yong PARK (Korea)
16:05-16:12 Post-operative Voiding Dysfunction and Detrusor Underactivity after BPH Surgery
Ho Young RYU (Korea)
16:12-16:30 Case-based Panel Discussion

Moderator: Jae Hyun RYU (Korea)
Panel: Hong Zoo PARK (Korea)   |   Teng Aik ONG (Malaysia)   |   Ji Hoon AHN (Korea)
Chung Lyul LEE (Korea)   |   Tae Yong PARK (Korea)   |   Ho Young RYU (Korea)
16:30-17:00 Best Abstract Prize Ceremony & Closing Remarks

Jae Young JOUNG (President, the Korean Prostate Society)
17:00 Banquet
go to top

Copyright(C) by 2026 KPS in conjunction with APSU Joint International Symposium.
All rights reserved.

Secretariat of KPS

Gaon Convention Services, Inc.
ADDRESS: ROOM 1005, 228, Gonghang-daero, Gangseo-gu, Seoul, Republic of Korea.
TEL : +82-2-6956-7989   |   E-MAIL : gaonpco@gaonpco.com

close

사전등록

등록구분
근무처
소속의사회

* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.